[go: up one dir, main page]

GB201819936D0 - Therapeutic methods - Google Patents

Therapeutic methods

Info

Publication number
GB201819936D0
GB201819936D0 GBGB1819936.4A GB201819936A GB201819936D0 GB 201819936 D0 GB201819936 D0 GB 201819936D0 GB 201819936 A GB201819936 A GB 201819936A GB 201819936 D0 GB201819936 D0 GB 201819936D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic methods
therapeutic
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1819936.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Almac Discovery Ltd
Original Assignee
Almac Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almac Discovery Ltd filed Critical Almac Discovery Ltd
Priority to GBGB1819936.4A priority Critical patent/GB201819936D0/en
Publication of GB201819936D0 publication Critical patent/GB201819936D0/en
Priority to BR112021010645-6A priority patent/BR112021010645A2/en
Priority to JP2021532119A priority patent/JP2022510700A/en
Priority to PCT/GB2019/053456 priority patent/WO2020115500A1/en
Priority to EP19821175.7A priority patent/EP3890737B1/en
Priority to AU2019393161A priority patent/AU2019393161A1/en
Priority to US17/299,971 priority patent/US20220016115A1/en
Priority to CN201980091404.7A priority patent/CN113395965A/en
Priority to SG11202105911PA priority patent/SG11202105911PA/en
Priority to KR1020217019978A priority patent/KR20210100127A/en
Priority to MX2021006542A priority patent/MX2021006542A/en
Priority to CA3121422A priority patent/CA3121422A1/en
Priority to IL283687A priority patent/IL283687A/en
Ceased legal-status Critical Current

Links

GBGB1819936.4A 2018-12-06 2018-12-06 Therapeutic methods Ceased GB201819936D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB1819936.4A GB201819936D0 (en) 2018-12-06 2018-12-06 Therapeutic methods
CA3121422A CA3121422A1 (en) 2018-12-06 2019-12-06 Usp19 inhibitors for use in therapy
US17/299,971 US20220016115A1 (en) 2018-12-06 2019-12-06 Usp19 inhibitors for use in therapy
JP2021532119A JP2022510700A (en) 2018-12-06 2019-12-06 USP19 inhibitor used in treatment
PCT/GB2019/053456 WO2020115500A1 (en) 2018-12-06 2019-12-06 Usp19 inhibitors for use in therapy
EP19821175.7A EP3890737B1 (en) 2018-12-06 2019-12-06 Usp19 inhibitors for use in a method of treating obesity, insulin resistance and type ii diabetes
AU2019393161A AU2019393161A1 (en) 2018-12-06 2019-12-06 USP19 inhibitors for use in therapy
BR112021010645-6A BR112021010645A2 (en) 2018-12-06 2019-12-06 compound, 1-(((s)-7-((r)-3-cyclohexyl-2-methylpropanoyl)-10-hydroxy-7-azaspiro[4.5]decan-10-yl)methyl)-4-phenyl-5 -(piperazine-1-carbonyl)pyridin-2(1h)-one, pharmaceutical composition, methods for treating obesity, insulin resistance, type II diabetes, muscle atrophy, cancer and to reduce muscle wasting, and, usp19 inhibitor
CN201980091404.7A CN113395965A (en) 2018-12-06 2019-12-06 USP19 inhibitors for treatment
SG11202105911PA SG11202105911PA (en) 2018-12-06 2019-12-06 Usp19 inhibitors for use in therapy
KR1020217019978A KR20210100127A (en) 2018-12-06 2019-12-06 therapeutic USP19 inhibitors
MX2021006542A MX2021006542A (en) 2018-12-06 2019-12-06 Usp19 inhibitors for use in therapy.
IL283687A IL283687A (en) 2018-12-06 2021-06-03 Usp19 inhibitors for use in therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1819936.4A GB201819936D0 (en) 2018-12-06 2018-12-06 Therapeutic methods

Publications (1)

Publication Number Publication Date
GB201819936D0 true GB201819936D0 (en) 2019-01-23

Family

ID=65029923

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1819936.4A Ceased GB201819936D0 (en) 2018-12-06 2018-12-06 Therapeutic methods

Country Status (1)

Country Link
GB (1) GB201819936D0 (en)

Similar Documents

Publication Publication Date Title
SG11202104461XA (en) Therapeutic methods
GB201820166D0 (en) Therapeutic agents
GB201820165D0 (en) Therapeutic agents
GB201804255D0 (en) Macrophage-based therapy
IL277336A (en) Combination therapy
GB201707153D0 (en) Therapy
GB201819853D0 (en) Therapy
IL292502A (en) Therapeutic methods using vadadustat
GB201805816D0 (en) Therapeutic agents
IL280729A (en) Combination therapy
IL279908A (en) Combination therapy
SG11202101518QA (en) Combination therapy
SG11202102878TA (en) Treatment methods
SG11202102827YA (en) Treatment methods
GB201817385D0 (en) Therapy
GB201818579D0 (en) New therapy
EP3721886C0 (en) Therapeutic method
GB201814036D0 (en) New therapy
GB201819936D0 (en) Therapeutic methods
GB201907647D0 (en) Therapeutic methods
GB201904341D0 (en) Therapeutic methods
GB201820895D0 (en) Therapy
GB201814038D0 (en) Ilven therapy
GB201807147D0 (en) Therapeutic combination
GB201809828D0 (en) Combined hormal therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)